---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-413233"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-10-05T12:45:07+00:00"
generated_at: "2026-10-12T14:47:14.298336+00:00"
event_type: "dividend"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health declares Series R preferred dividend, amends royalty and note obligations

## Summary
- Board declared special one-time dividend of one Series R Convertible Preferred share per common share; record date Oct 13, 2026, payment date Oct 15, 2026.
- Series R designates 2,325,000 preferred shares; each converts into 5 common shares on Nov 2, 2026, up to 11,625,000 conversion shares.
- Example: 2,281,247 Series R shares would yield 11,406,235 common shares, about 83.3% of outstanding common stock after conversion.
- Uptown and Streeterville royalty amendments extend monthly payments from Oct 1, 2026 to Jan 1, 2027; monthly Royalty Payment is greater of $750,000 or actual amount.
- 2021 Note maturity extended from Oct 1, 2026 to Jan 1, 2027; C/M Capital consented to dividend and Series R authorization.

## SEC filing metadata
- accession: 0001193125-26-413233
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-10-05T12:45:07+00:00
- event_type: dividend
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 1.01, 2.03, 3.03, 8.01, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526413233/0001193125-26-413233-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526413233/d183888d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-413233
- JSON: https://secwatch.observer/filing/0001193125-26-413233.json
- Plain text: https://secwatch.observer/filing/0001193125-26-413233.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.